Bacterial Infections and Mycoses
At Niepubliczny Zaklad Opieki Zdrowotnej Salmed, the research team is dedicated to preventing meningococcal infection by evaluating new vaccine options for young children.
- Development of a conjugate vaccine targeting serogroups A, C, W, and Y
- Assessment of immunogenicity in infants and toddlers
- Safety monitoring in healthy volunteers
- Comparison of antibody responses to an established vaccine
The ongoing studies aim to demonstrate non‑inferior immune protection using geometric mean titers as a measure of response, while also confirming the safety profile of the investigational MenACYW conjugate vaccine in this pediatric population.
